XML 23 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Capital in Excess of Par Value
Capital in Excess of Par Value
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Undistributed (Overdistributed) Earnings
Accumulated Undistributed (Overdistributed) Earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2020     423,000,000        
Beginning balance at Dec. 31, 2020 $ 7,176   $ 0 $ 7,656   $ (480)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock, net of offering and underwriting costs (in shares)     42,000,000        
Issuance of common stock, net of offering and underwriting costs $ 819     819      
Shares issued in connection with dividend reinvestment plan (in shares) 1,900,000   3,000,000        
Shares issued in connection with dividend reinvestment plan $ 38     38      
Net investment income 741         741  
Net realized gains (losses) on investments, foreign currency, extinguishment of debt and other transactions 240         240  
Net unrealized gains (losses) on investments, foreign currency and other transactions 586         586  
Dividends declared and payable (732)         (732)  
Tax reclassification of stockholders’ equity in accordance with GAAP 0     40   (40)  
Ending balance (in shares) at Dec. 31, 2021     468,000,000        
Ending balance at Dec. 31, 2021 8,868 $ (2) $ 0 8,553 $ (4) 315 $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock, net of offering and underwriting costs (in shares)     50,000,000        
Issuance of common stock, net of offering and underwriting costs $ 1,001   $ 1 1,000      
Shares issued in connection with dividend reinvestment plan (in shares) 1,500,000   1,000,000        
Shares issued in connection with dividend reinvestment plan $ 29     29      
Net investment income 1,092         1,092  
Net realized gains (losses) on investments, foreign currency, extinguishment of debt and other transactions 33         33  
Net unrealized gains (losses) on investments, foreign currency and other transactions (525)         (525)  
Dividends declared and payable (941)         (941)  
Tax reclassification of stockholders’ equity in accordance with GAAP 0     (22)   22  
Ending balance (in shares) at Dec. 31, 2022     519,000,000        
Ending balance at Dec. 31, 2022 9,555   $ 1 9,556   (2)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock, net of offering and underwriting costs (in shares)     61,000,000        
Issuance of common stock, net of offering and underwriting costs $ 1,155     1,155      
Shares issued in connection with dividend reinvestment plan (in shares) 2,500,000   2,000,000        
Shares issued in connection with dividend reinvestment plan $ 47     47      
Net investment income 1,266         1,266  
Net realized gains (losses) on investments, foreign currency, extinguishment of debt and other transactions (179)         (179)  
Net unrealized gains (losses) on investments, foreign currency and other transactions 435         435  
Dividends declared and payable (1,078)         (1,078)  
Tax reclassification of stockholders’ equity in accordance with GAAP 0     (20)   20  
Ending balance (in shares) at Dec. 31, 2023     582,000,000        
Ending balance at Dec. 31, 2023 $ 11,201   $ 1 $ 10,738   $ 462